Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

There are currently no FDA-approved broth microdilution antifungal susceptibility testing products or interpretive breakpoints for susceptibility testing of the new triazole posaconazole. Fluconazole and voriconazole are in the same triazole class as posaconazole, have CLSI-approved interpretive MIC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., Diekema, D. J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology (ASM) 2008
Ämnen:
Mycology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238086/
https://ncbi.nlm.nih.gov/pubmed/18094129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01952-07
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk